HC Wainwright & Co. Downgrades Lipocine to Neutral

Benzinga Newsdesk www.benzinga.com Negative 89.1%

Neg 89.1% Neu 0% Pos 0%

HC Wainwright & Co. analyst Yi Chen downgrades Lipocine (NASDAQ:LPCN) from Buy to Neutral.

Comments

No comments yet. Be the first!

HC Wainwright &amp; Co. Downgrades Lipocine to Neutral